As AFP has long been considered the gold-standard biomarker in HCC diagnosis, several studies have assessed MDK expression and serum levels in HCC patients in comparison with AFP (please see Table 1 and Table 2). This evidence concerns the gene AFP and hepatocellular carcinoma.